Traumatic Brain Injuries Assessment And Management Devices Market Size, Share & Trends Analysis Report By Device (Imaging, Monitoring Devices), By Technique (pBrO2, ICP Monitoring), By End Use, And Segment Forecasts, 2022 - 2030

Report Overview

The global traumatic brain injuries assessment and management devices market size was valued at USD 2.89 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. The increasing prevalence of TBIs, rising patients’ preference for minimally invasive procedures, as well as raising awareness regarding brain injury treatment are the major factors expected to drive the traumatic brain injuries (TBIs) assessment and management devices market growth. In addition, the adoption of technologically advanced products, and supportive government policies are a few more factors contributing to the market growth.TBIs are permanent or temporary impairments to the brain that can be caused by a blow, bump, or shock to the skull.

Major causes for TBIs include sports injuries, falls, gunshot wounds, domestic violence, and road traffic accidents. As per the CDC, TBI is responsible for 2.8 million accidents and emergency department visits annually in the U.S. Furthermore, according to Stanford Children’s Health, over 3.5 million sports-related injuries are reported annually among children in the U.S and around 21% of all are TBIs. Thus, increasing cases of TBIs due to sports injuries, road accidents, and assaults are anticipated to boost the market growth during the forecast period. The outbreak of COVID-19 in the year 2020 had a short-term and moderate impact on the market by directly affecting the demand & production, creating a disruption in the supply chain, and increasing the financial burden on firms.

To reduce the spread of the coronavirus, brain surgeries have frequently been postponed or even canceled during this timeframe. In worst-affected nations, such as the U.S., Russia, India, Brazil, France, the U.K., Italy, and Spain, neurosurgical operations fell by 55%. However, according to a study published in the Elsevier journal (International Hemorrhagic Hospital Association) (Jan 2021) titled “COVID-19 and Hospital: A review”, up to 36% of hospitalized COVID-19 patients may experience neurological symptoms, and there have been several cases of ischemic and hemorrhagic infarction. Another recent research study published in Neurology Online Journal proposes that the COVID-19 virus might be responsible for patients acquiring novel neurological diseases.

These findings also suggest that COVID-19 might enhance sales in the neurology industry. Thus, these factors are expected to create lucrative growth opportunities for the market. Moreover, a rise in patients’ preference for minimally invasive neurosurgeries is expected to boost market growth. Currently, most TBIs can be primarily handled using minimally invasive devices, such as MRI or CT scanning, transcranial Doppler ultrasound, and endoscopy to remove hematomas or contusions that occurred after the brain injury. Such specialized devices make it feasible for neurosurgeons to reach deep lesions in the brain through a pinhole-sized opening in the skull, without damaging the surrounding tissues.

Thus, rising demand for minimally invasive neuro procedures owing to less pain and chances of infection along with speedy recovery is expected to boost the demand for TBIs assessment and management devices. Furthermore, an increasing number of initiatives and programs being undertaken by the governments of various countries about brain injuries are expected to fuel the market growth. For instance, the Brain Injury Association of America (BIAA) as an initiative toward traumatic brain injuries organizes a national public awareness campaign in March every year to emphasize the importance of acknowledging the impact of brain injuries.

The campaign ‘Change Your Mind’ from 2018 to 2020 educates the public about the occurrence of brain injury and the needs of people with brain injuries and their families. Similarly, Defense and Veterans Brain Injury Center (DVBIC) offers online education for both civilian and military providers to learn about traumatic brain injury to promote the best possible care for service members and veterans around the world. Thus, growing awareness among people regarding the treatment to prevent the rate of TBIs is likely to boost the market growth. Countries, such as the U.S. and Canada, have witnessed a high prevalence rate of TBIs due to road accidents, sports injuries, and assaults.

Gunshots or explosive blast exposure are a common cause of TBIs in active-duty military personnel. For instance, as per the Defense and Veterans Brain Injury Center (DVBIC), between 2000 and late 2019 around 414,000 TBIs have been reported among U.S. military members. According to the Brain Injury Association Waterloo-Wellington, over 11,000 individuals die due to TBIs every year in Canada, and over 6,000 become permanently disabled post-TBIs. Therefore, such a high prevalence rate of TBIs is estimated to boost the market growth over the forecast period.

In addition, the increasing incidence of TBIs due to road accidents and falls in developed and developing countries has driven the launch of technologically advanced products in the market. For instance, BrainScope, a U.S.-based company, has been granted over USD 32 million from the U.S. Department of Defense research contracts for the development of its BrainScope One device. It is an EEG-based non-invasive technology that enables decision-making on the spot. In addition, in June 2019, Nihon Kohden launched a wireless Electroencephalogram (EEG) headset in the U.S. called VitalEEG to promptly assess brain activity in unconscious patients. This is anticipated to boost the demand for TBIs assessment and management devices during the forecast period.

Device Insights

Based on devices, the global market has been further segmented into imaging devices and monitoring devices. The imaging devices segment dominated the global market in 2021 and accounted for the largest share of more than 53.5% of the overall revenue. The imaging devices segment is further sub-categorized into Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI) devices, X-ray, and others. Due to higher sensitivity, imaging devices are widely used to assess patients with mild or severe TBI. Thus, increasing application scope in the diagnosis and staging of neurological diseases & disorders, particularly TBIs, is expected to drive the segment.

On the other hand, the monitoring devices segment is expected to register the fastest growth rate from 2022 to 2030 on account of the minimally invasive nature of these devices and increasing awareness and improvements in healthcare facilities. In addition, factors, such as greater accuracy of these devices, increasing patient preference for non-invasive procedures, and a high preference among physicians for brain disease progression monitoring, are expected to drive the growth of this segment during the forecast period.

Technique Insights

Based on techniques, the market has been segmented into Intracranial Pressure (ICP) monitoring and partial pressure of oxygen in brain tissue (pBrO2). The ICP monitoring segment dominated the market with a revenue share of more than 54.00% in 2021. This method is considered a gold standard for the measurement of accurate increased intracranial pressure in patients with severe brain injury. Several studies have recommended that raised ICP is the common cause of death in patients with TBI. Therefore, continuous ICP monitoring helps in keeping the pressure levels in a normal range and provides early and effective treatment.

Thus, the advantages offered by ICP monitoring and an increasing number of TBI patients are expected to boost the market growth. However, the partial pressure of oxygen in the brain tissue monitoring segment is expected to grow at the fastest CAGR from 2022 to 2030. Continuous pBrO2 monitoring provides timely information about cerebral oxygen demand in patients suffering from TBI. The pBrO2 monitoring systems provide continuous monitoring of partial pressure of oxygen in brain tissue, thus, providing an early indication of hypoxic events. These factors are anticipated to boost the segment growth during the forecast period.

End-use Insights

Based on end-uses, the global market has been segmented into hospitals, diagnostic centers, and others. The hospital's segment dominated the market in 2021 and accounted for the maximum share of 43.00% of the overall revenue. This growth was mainly attributed to a rise in the number of brain surgeries performed in hospitals as well as an increase in the prevalence of TBI patients across the globe. In addition, hospitals are well equipped with technologically advanced devices that are used by professional neurologists, which is expected to boost the segment growth over the forecast period.

However, the other segment, which includes Ambulatory Surgical Centers (ASCs), research centers, and emergency clinics is expected to register the fastest CAGR from 2022 to 2030. This growth can be attributed to various advantages offered by emergency clinics and ASCs, such as shorter procedure time and same-day discharge, over hospitals. Furthermore, most brain surgeries can now be performed at ASCs, as these procedures turn out to be more advanced and less invasive. Thus, the growth of the other segment is majorly attributed to inexpensive and ongoing advancements in minimally invasive surgical techniques as well as shorter procedure times.

Regional Insights

North America dominated the market with a share of more than 52.00% in 2021. This is attributed to the presence of well-established healthcare facilities in the region, increasing government initiatives, awareness campaigns regarding brain injuries, and greater incidence of TBIs in the continent. For instance, as per the CDC, an expected 2.87 million individuals in the U.S. sustain brain injuries and 1.5 million Americans sustain a TBI annually. In the U.S, at present more than 5.3 million people have a permanent TBI-related disability. These incidence rates involve around 2.5 million TBI-related emergency department visits, 288,000 hospitalizations, and 56,800 deaths.

Thus, contributing to the market growth in the region. The Asia Pacific region is expected to grow at the highest CAGR from 2022 to 2030. This is due to the factors, such as growth in the aging population, a rise in the number of people suffering from TBIs, an increasing incidence of road accidents, and violence. For instance, according to the Ministry of Road Transport and Highways, Government of India, around 4.5 million people were injured in road accidents in 2016. This number has increased by 25.6% from 2007 to 2017. In addition, growing patient affordability has together resulted in a significant number of interventional procedures in the Asia Pacific region.

Key Companies & Market Share Insights

Companies are stressing research and development to develop technologically advanced products to gain a competitive edge. For instance, in January 2019, Oculogica Inc, has received the U.S. FDA request for the marketing of the EyeBOX device. This device uses eye-tracking to help in the diagnosis of patients with suspected concussions in a 4-minute test. Moreover, in June 2019, Nihon Kohden launched a wireless EEG headset in the U.S.-VitalEEG-to promptly assess brain activity in unconscious patients.

Moreover, key companies are adopting various strategies, such as product launches, M&As, partnerships, and geographical expansions to strengthen their foothold in the market. For instance, in September 2019, Integra Life Sciences completed the acquisition of Rebound Therapeutics, a manufacturer of disposable medical devices. With this acquisition, the company developed new products and a minimally invasive platform for neurosurgery. Some of the prominent players in the global traumatic brain injuries assessment and management devices market include:

• Integra Lifesciences

• BioDirection, Inc.

• Nihon Kohden Corp.

• Compumedics Ltd.

• InfraScan, Inc.

• Oculogica

• Raumedic AG

Traumatic Brain Injuries Assessment And Management Devices Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global traumatic brain injuries assessment and management devices market report based on device, technique, end-use, and region:

• Device Outlook (Revenue, USD Million, 2018 - 2030)

  • Imaging Devices

  • Magnetic Resonance Imaging (MRI) Devices

  • X-Ray

  • Computed Tomography

  • Others

  • Monitoring Devices

• Technique Outlook (Revenue, USD Million, 2018 - 2030)

  • Intracranial Pressure (ICP) Monitoring

  • Partial Pressure of Oxygen in Brain Tissue (pBrO2)

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Diagnostic Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE